Literature DB >> 1964939

Development of the polymerase chain reaction for the detection of bluetongue virus in tissue samples.

A M Wade-Evans1, P P Mertens, C J Bostock.   

Abstract

Total genomic dsRNA, extracted from purified core particles of bluetongue virus serotype 1 from South Africa (BTV1SA), was used as template to optimise a polymerase chain reaction (PCR) for the detection of bluetongue virus RNA. Pairs of oligonucleotides complementary to the 3' termini of eight of the ten genome segments were tested. Those representing the 5' termini of genome segment 7 gave the best amplification results producing a single DNA band with the same mobility during agarose gel electrophoresis as genome segment 7. It was confirmed by cloning and sequence analysis, that this PCR-amplified DNA contained both terminal regions of genome segment 7 and therefore represented full length cDNA. Using these segment 7 oligonucleotides it was not only possible to detect routinely as few as 6 molecules of segment 7 dsRNA per sample, but also to detect purified dsRNAs from isolates of other BTV serotypes (1 Australia (AUS), 2, 3, 4, 10, 16 and 20). However, with the exception of Tilligery virus, isolates from other Orbivirus serogroups tested all gave negative results (African horse sickness, epizootic haemorrhagic disease, Palyam, Warrego and Eubenangee). The PCR was also used to analyse red blood cells (RBC) and buffy coat samples from cattle infected with BTV4. Positive results were obtained from samples taken 7 days post-infection (p.i.) (containing 1.6 x 10(3) TCID50 of virus/ml of whole blood) and from the RBC sample only, taken 14 days p.i. (16 TCID50/ml). However, at 28 days p.i. (less than 1.6 TCID50/ml) BTV RNA was not detected using the PCR in either sample.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964939     DOI: 10.1016/0166-0934(90)90040-m

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  9 in total

1.  Characterization of an Indian bluetongue virus isolate by RT-PCR and restriction enzyme analysis of the VP-7 gene sequence.

Authors:  A K Tiwari; R S Kataria; G Desai; G Butchaiah; S K Bandyopadhyay
Journal:  Vet Res Commun       Date:  2000-09       Impact factor: 2.459

2.  Association of bluetongue virus gene segment 5 with neuroinvasiveness.

Authors:  M A Carr; C C de Mattos; C A de Mattos; B I Osburn
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Evidence of bluetongue virus serotype 21 (BTV-21) divergence.

Authors:  B Susmitha; D Sudheer; Pavuluri Panduranga Rao; Madala Uma; Gaya Prasad; P Minakshi; Nagendra R Hegde; Y Narasimha Reddy
Journal:  Virus Genes       Date:  2012-02-18       Impact factor: 2.332

4.  PCR detection of North American and Central African isolates of epizootic hemorrhagic disease virus (EHDV) based on genome segment 10 of EHDV serotype 1.

Authors:  I E Aradaib; W C Wilson; C E Schore; M E Mohammed; T D Yilma; J S Cullor; B I Osburn
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Detection of African horse sickness virus by reverse transcription-PCR.

Authors:  M Stone-Marschat; A Carville; A Skowronek; W W Laegreid
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Development of polymerase chain reaction for specific identification of epizootic hemorrhagic disease virus serotype 1.

Authors:  I E Aradaib; J W McBride; W C Wilson; B I Osburn
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Ring trial 2016 for Bluetongue virus detection by real-time RT-PCR in France.

Authors:  Corinne Sailleau; Cyril Viarouge; Emmanuel Breard; Damien Vitour; Stephan Zientara
Journal:  Vet Med Sci       Date:  2017-04-16

Review 8.  Detection of animal pathogens by using the polymerase chain reaction (PCR).

Authors:  J M Rodriguez
Journal:  Vet J       Date:  1997-05       Impact factor: 2.688

Review 9.  Application of the polymerase chain reaction (PCR) in veterinary diagnostic virology.

Authors:  S Belák; A Ballagi-Pordány
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.